xPEDition pain: protocol for a quasi-experimental before–after study of a public health campaign on chronic pain in the Ems Dollart Region Authors: AY Sanina, MF Reneman, BL Seves, AP Wolff, C Bantel, S Beinert, M Montes-Martínez, GL Moseley, C Ryan, P van Wilgen, K Tamasi, L Schwettmann, R Soer Published: 2026 ABSTRACT Abstract AbstractIntroductionChronic pain is a public health priority that affects 18% of Dutch and 16% of German adults, representing a major societal burden. The Ems Dollart Region (EDR), which forms the northern part of the Dutch–German border area, is particularly characterised by lower incomes, more physically demanding jobs and lower health literacy, which are associated with higher pain prevalence. Individuals with lower socioeconomic status face greater pain-related disability and reduced quality of life. Public health campaigns underpinned by pain science education provide a strategy to improve understanding of pain among the wider public by addressing common misconceptions about its causes and management. However, large-scale population-level interventions and evaluations of such campaigns remain limited.Methods and analysisThis protocol describes the design and implementation of a cross-border public health campaign in the EDR, aimed at improving public understanding of pain, changing attitudes and beliefs and promoting healthy behaviours. We will conduct a quasi-experimental before–after study in the EDR with a control group in Flanders (Belgium). The intervention is guided by behaviour change and biopsychosocial models. The campaign will deliver tailored content via social media, broadcast, print and online advertisements over a 24-month period. Two independent cross-sectional samples will be surveyed at baseline and at 2-year follow-up, comprising 3200 participants per measurement wave from three regions: the Netherlands and Germany as intervention regions, and Flanders, Belgium, as the control region. The primary outcome is the prespecified Pain Concepts Questionnaire ratio score, assessing pain-related knowledge, attitudes and beliefs. The primary analysis will use an adjusted difference-in-differences framework to estimate whether change in the primary outcome differs between the combined intervention regions and the control region. Secondary analyses will examine the Netherlands and Germany separately and will evaluate healthcare utilisation, medication use, health-related quality of life and work absenteeism.Ethics and disseminationThis study protocol was reviewed by the Medical Ethics Review Board of the University Medical Center Groningen and the University of Oldenburg. The study was considered not subject to the Medical Research Involving Human Subjects Act (non-WMO declaration; reference number M24.345555, issued on 31 December 2024) and was approved by the University of Oldenburg Ethics Committee (reference number 2025–056, issued on 07 March 2025). Informed consent was obtained electronically by the research agency at the time of participants’ registration with the research panel. Study findings, regardless of outcome, will be disseminated through peer-reviewed publications and presentations at national and international conferences.Keywords: Chronic Pain, Health Literacy, PUBLIC HEALTH, Preventive Health Services, PAIN MANAGEMENT, Health Care Costs STRENGTHS AND LIMITATIONS OF THIS STUDY This is a cross-border study, which increases the generalisability of the findings. This is a cross-border study, which increases the generalisability of the findings. The primary outcome is assessed with a questionnaire previously validated in populations that included individuals from low socioeconomic status backgrounds. The primary outcome is assessed with a questionnaire previously validated in populations that included individuals from low socioeconomic status backgrounds. A spillover effect of the campaign between the Netherlands and Flanders (Belgium) cannot be excluded, due to the shared language. A spillover effect of the campaign between the Netherlands and Flanders (Belgium) cannot be excluded, due to the shared language. The quasi-experimental design with independent samples at different time points allows assessment of changes in public knowledge and shifts in attitudes and beliefs, but it does not capture these changes at the individual level. The quasi-experimental design with independent samples at different time points allows assessment of changes in public knowledge and shifts in attitudes and beliefs, but it does not capture these changes at the individual level. Introduction Chronic pain significantly impacts populations across the globe and represents a major public health concern, affecting more than a quarter of people worldwide.1 The prevalence of moderate-to-severe general chronic pain among Dutch and German adults has been estimated to be 18% and approximately 16%, respectively.2 3 Additionally, in the Netherlands, the prevalence of unexplained severe chronic pain in general practice has been described as 7.9 per 1000 enlisted patients, while the prevalence of general chronic musculoskeletal pain in the adult population has been estimated at 44.4%.2 Chronic pain is associated with a considerable economic and societal burden, largely driven by healthcare utilisation and productivity losses.3 4 Despite the widespread burden of chronic pain in the Netherlands and Germany, the Ems Dollart Region (EDR) includes peripheral areas characterised by lower socioeconomic status (SES), lower educational attainment, poorer health and more physically demanding work, factors associated with a higher burden of chronic pain.5 6 The EDR includes three Dutch provinces (Drenthe, Friesland and Groningen) and the western part of Lower Saxony in Germany, comprising 13 districts (Emsland, Leer, Emden, Aurich, Wittmund, Friesland, Cloppenburg, Vechta, the city and county of Oldenburg, Ammerland, Wesermarsch and Wilhelmshaven) with a total population of approximately 2.8 million. The EDR is characterised by considerable socioeconomic heterogeneity. While some German districts, such as Emsland, are characterised by relatively favourable socioeconomic conditions, others, like Wilhelmshaven, are former industrial centres facing structural socioeconomic challenges.7 Similarly, peripheral areas in Groningen and Drenthe show higher rates of poverty, unemployment and poorer health than national averages, whereas other parts of the region are more socioeconomically affluent areas.5 These socioeconomic disparities are important because individuals with lower SES are disproportionately affected by chronic pain.6 They not only have a higher prevalence of chronic pain but also report more chronic diseases, and a lower health-related quality of life than those with higher SES.6 8 SES often interacts with other contextual factors, such as regional characteristics and occupational demands, shaping both pain experiences and how people perceive and act on information about pain and health.6 A key factor in this relationship is health literacy: lower vocational education levels are strongly linked to poorer health literacy, which in turn affects quality of life, health behaviours and preventive care use.9 10 Improving health literacy has been associated with lower pain intensity in chronic pain populations, through more informed decision-making about pain, adoption of healthier coping strategies and more effective engagement in self-management.11 12 Evidence suggests that public pain education campaigns can benefit population-level understanding of pain, as reflected in national pain strategies.13 Pain science education (PSE), an educational approach that explains ‘how pain works’ by addressing its biological, psychological and social characteristics,14 15 appears particularly promising. PSE distinguishes itself from general pain education by including an explanatory component that helps individuals reconceptualise pain as less threatening and more manageable. However, up to half of all public health education campaigns risk increasing health inequities, a challenge that can be mitigated by involving target groups in the design and delivery process.16 Preliminary findings indicate that co-designed, PSE-based public education can improve pain-related understanding across all socioeconomic groups within the general population.17 18 To maximise their reach and impact, consistent reinforcement of PSE across different settings is needed. Healthcare professionals (HCPs) play an important role in this process, as their communication can influence public beliefs. However, variation in healthcare messaging has been reported, underscoring the need for improved alignment with evidence-based information in patient care.19 20 Although PSE-based public education has shown promise, most initiatives remain small-scaled and fragmented and do not specifically target disadvantaged groups and different cultural contexts.21 22 To maximise the impact and sustainability of such interventions, it is essential not only to evaluate their impact in changing knowledge, attitudes, beliefs and behaviours, but also to examine their cost-benefit.17 Our project will integrate public health education with training for HCPs, ensuring that evidence-based messages are reinforced both in media outreach and clinical practice, creating a messaging ripple effect. Given the strong associations between SES, health literacy and pain-related outcomes, the campaign specifically aims to reach diverse population groups at increased risk of chronic pain, including individuals with lower educational levels or limited health literacy, those in physically demanding occupations and athletes. The present study aims to design and implement a public health campaign that educates the general population about chronic pain by improving knowledge, fostering shifts in attitudes and beliefs and thereby encouraging healthy behaviours. The sub-aims are (1) to investigate the associations between the implementation of the campaign and changes in pain-related knowledge, attitudes, beliefs and health behaviours and (2) to estimate cost effects and initiate a cost-benefit analysis to assess its economic and societal value in terms of healthcare utilisation and medication use. Methods and analysis Study design A quasi-experimental before–after study will be conducted to evaluate the effects of the public health campaign. Pre-intervention and post-intervention surveys will be administered in both the intervention and control regions, allowing comparison of changes over time between regions exposed and not exposed to the campaign. The reporting of this protocol was guided by an adapted version of the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2025 checklist, as not all items were applicable to this non-randomised, quasi-experimental study. Intervention design The Behaviour Change Wheel (BCW) was used as a comprehensive framework to characterise, design and evaluate the public health campaign ‘xPEDition Pain’, our intervention. To provide additional theoretical underpinning, we also incorporated the attitude–social influence–self-efficacy (ASE) model and the biopsychosocial (BPS) model, which together offer a conceptual foundation for understanding the key psychological, social and biological factors of health-related behaviours.15 23 Integrating these models within the BCW allowed us to target the most relevant determinants for the identified population groups. This helped ensure that the intervention was tailored to their needs, was supported by evidence from previous public health campaigns and had greater potential impact. Building on this evidence, we defined behavioural objectives and linked them to intervention strategies, leading to the concrete intervention elements described in table 1. Table 1Linking theoretical models (BCW, ASE and BPS) to behavioural targets and intervention strategiesBCW componentModel(s)What to do?(behavioural objectives)How to do it?(intervention strategies)Capability(psychological and physical ability)ASE: Self-efficacyBPS: Psychological and biological Increase knowledge.Provide self-management tools.Build confidence.Correct misinformation. Educational posts.Testimonials from peers.Emphasise self-efficacy and control. Opportunity(external factors that enable or prompt behaviour)ASE: Social influenceBPS: Social Facilitate peer learningInvolve role modelsPromote community engagement.Address social norms. Create online support groupsPartner with influencersOrganise workshops/events.Distribute accessible materials, including education of HCPs. Motivation(internal processes: habits, emotions, decisions)ASE: AttitudeBPS: Psychological Change negative beliefs.Encourage positive mindset.Promote self-management.Debunk misconceptions. Provide PSE-based information.Share success stories.Use visuals and emotional framing. ASE, attitude–social influence–self-efficacy; BCW, Behaviour Change Wheel; BPS, biopsychosocial model; HCP, healthcare professional; PSE, pain science education. Linking theoretical models (BCW, ASE and BPS) to behavioural targets and intervention strategies Increase knowledge. Increase knowledge. Provide self-management tools. Provide self-management tools. Build confidence. Build confidence. Correct misinformation. Correct misinformation. Educational posts. Educational posts. Testimonials from peers. Testimonials from peers. Emphasise self-efficacy and control. Emphasise self-efficacy and control. Facilitate peer learning Facilitate peer learning Involve role models Involve role models Promote community engagement. Promote community engagement. Address social norms. Address social norms. Create online support groups Create online support groups Partner with influencers Partner with influencers Organise workshops/events. Organise workshops/events. Distribute accessible materials, including education of HCPs. Distribute accessible materials, including education of HCPs. Change negative beliefs. Change negative beliefs. Encourage positive mindset. Encourage positive mindset. Promote self-management. Promote self-management. Debunk misconceptions. Debunk misconceptions. Provide PSE-based information. Provide PSE-based information. Share success stories. Share success stories. Use visuals and emotional framing. Use visuals and emotional framing. ASE, attitude–social influence–self-efficacy; BCW, Behaviour Change Wheel; BPS, biopsychosocial model; HCP, healthcare professional; PSE, pain science education. This campaign content was adapted to a B1 language level, according to the Common European Framework of Reference for Languages. This was intended to ensure that individuals with limited language skills can also engage with the material, thereby supporting broad demographic engagement across the intervention regions. Special attention was given to tailoring content to target populations by using accessible channels (eg, regionally popular social media platforms, workplace communication channels and sports club networks) and by developing materials through co-creation, such as interviews with target populations and collaboration with relevant stakeholders. In parallel, a PSE training programme was developed for HCPs in the region, aimed at aligning public messages with clinical communication and promoting a consistent biopsychosocial approach to pain. Compared with the public campaign, this programme was designed to provide a more advanced PSE curriculum tailored to the needs of HCPs and included lectures, interactive workshops and question and answer sessions, with accreditation provided where feasible. The programme also supported the development of a regional pain network to facilitate knowledge exchange and sustain PSE-informed practice beyond the campaign period. Content was developed by the research team and the public relations company, based on predefined key messages derived from the theoretical framework and input from interviews with the target populations (see table 2). The overarching content of the posts covered information about the project, pain-related data and facts, as well as practical tips and strategies to prevent chronic pain and promote self-management in everyday life. Table 2Key messages in the xPEDition Pain campaignModel componentsKey messagesASE: AttitudeBPS: PsychologicalStay as active as possible.Positive attitudes, mindsets and emotions are important.Emotions matter.Pain and tissue damage are poorly related.Surgery, pills, scans and X-rays are not always the (best) solution.Understanding your pain can be key.Pain system sensitivity means you can feel pain without a clear somatic cause.ASE: Social influenceBPS: SocialYou are not alone, and pain can be treated.You are not alone; chronic pain is common and can affect anyone.Pain should not dominate your life.Connect with peers/others, their support can help you/can help you manage your pain.ASE: Self-efficacyBPS: Psychological and biologicalYou can retrain your pain system to be less protective.You can retrain your pain system by gradually increasing your physical activity.There is a lot you can do to help yourself.Boost your confidence by learning more about how pain works.ASE, attitude–social influence–self-efficacy; BPS, biopsychosocial model. Key messages in the xPEDition Pain campaign ASE, attitude–social influence–self-efficacy; BPS, biopsychosocial model. Theoretical framework Behaviour change wheel The BCW provides the overarching framework. It outlines that behaviour is influenced by three key determinants: individual’s capability, their opportunity to act and their motivation to engage in the desired behaviour. In our campaign, capability was targeted by increasing knowledge, skills and confidence. Opportunity was targeted by strengthening peer and community engagement and motivation by changing negative beliefs, fostering a positive mindset and promoting self-management. These behavioural objectives were linked to the intervention functions of education (to increase knowledge), persuasion (to influence motivation and attitudes), modelling (to demonstrate positive approaches to pain) and enablement (to remove barriers and support behaviour change). In addition, training and environmental restructuring were incorporated to support HCPs in integrating the campaign messages into clinical practice.24 Attitude–social influence–self-efficacy The ASE model explains behaviour through three key determinants: attitudes, social influence and self-efficacy. In our campaign, attitudes were addressed by correcting misconceptions and fostering positive beliefs, social influence by involving peers, communities and role models, as well as self-efficacy by providing tools and strategies to build confidence in managing pain. Biopsychosocial model The BPS model highlights that health and illness are influenced by the interaction of biological, psychological and social factors.23 Our campaign was designed to reflect a multidimensional perspective of pain, namely through psychological processes (beliefs, emotions, confidence), social context (norms, peer engagement) and biological understanding and self-management aspects (knowledge, self-management tools). Table 1 summarises this translation from theory to practice, outlining how the BCW, ASE and BPS models guided the selection of behavioural objectives and corresponding intervention strategies. Intervention procedures The campaign takes place over 24 months, from May 2025 to May 2027. Designed to increase public awareness and understanding of pain and pain management, the xPEDition Pain (in Dutch: xPEDitie Pijn; in German: xPEDition Schmerz) campaign, focuses on disseminating information through accessible content. The content will be shared through a campaign website in German and Dutch (www.xped.net), as well as social, broadcast and print media channels such as Facebook, Instagram, radio, television and newspapers. Social media posts will be published two times a week, while local radio and television advertisements will be broadcast periodically. In addition, Google advertisements and influencers will be involved in disseminating the campaign content. Based on keyword research, we will create both general advertisements to increase awareness of the campaign and more targeted advertisements linked to specific pain-related search terms and population groups. Advertisements will initially focus on increasing traffic to the campaign website and will later shift towards specific actions, such as newsletter sign-ups or contact requests. Campaign performance will be periodically reviewed using platform analytics and Google Analytics 4, and insights will be used to refresh and refine content and delivery throughout the campaign period. The broader project timeline, which includes the campaign period, is outlined in table 3. Table 3Project timelineActivityPlanned periodDescriptionProject preparationJan 2024–Apr 2025Development of campaign materials, ethical approvalsBaseline survey (T0)Campaign startApr–May 2025Online survey (n=3200)Website launchMay 2025Launch of central campaign website with key messages and resourcesSocial media roll-outMay 2025Start of campaign via social media platforms (Facebook, Instagram)Broadcast media roll-outNov 2025Start of television and radio campaignPrint media roll-outFrom Oct to Nov 2025 onwardsStart of campaign in newspapers, magazines and other printed materialsGoogle-Ads roll-outSep 2025General brand ads+targeted ads based on keyword research; initial goal: website trafficInfluencer involvementFrom Oct 2025 onwardsCollaboration with influencers to increase campaign outreach via social mediaCampaign event (outreach)From Jan 2026 onwards‘A year in motion’: A type of movement is being promoted every month (eg, January-aquafitness)Professional educationFrom Jan 2026 onwardsDelivery of PSE training for healthcare professionals, offering advanced education to support the application of biopsychosocial pain principles in clinical reasoning and communicationAd targeting optimisationAfter sufficient data collectionShift from general reach (traffic) to targeted actions (newsletter sign-ups, contact requests)Performance monitoringOngoing (monthly)Use platform analytics+Google Analytics 4 to review reach and engagement; refresh content regularlyFollow-up survey (T1)Apr–May 2027Online survey (n=3200)Project completionMay–Sep 2027Data analysis, reporting, disseminationPSE, pain science education. Project timeline PSE, pain science education. Target population and recruitment The target population for the campaign is the general population in the EDR, with specific attention to socioeconomically disadvantaged groups, individuals with limited health literacy, those with physically demanding jobs and athletes at higher risk of chronic pain and excessive or preventive non-steroidal anti-inflammatory drug use. Survey participants will be recruited independently of the campaign, using two independent cross-sectional cohorts drawn from the existing panel of a professional research agency. This agency maintains a large online panel of residents from the target regions who have voluntarily registered to participate in population surveys for research and marketing purposes. Since individuals in these cohorts are already members of the agency’s panel assisting with survey distribution, they have provided prior consent to be approached for participation on registering with the agency. All data will be collected anonymously. Two online surveys will be distributed among random samples of individuals from these cohorts, comprising members of the general population in the EDR and the Flemish adult population. The composition of the panel is designed to reflect the general population in terms of demographic (age, gender) and socioeconomic characteristics (educational level, employment status), thereby targeting a representative sample. The control group will be recruited from the Flanders region in Belgium, which is not intended to be exposed to the campaign. Flanders was chosen because it is geographically close and socioculturally comparable to the intervention regions, yet not targeted by Dutch or German campaign channels, thereby minimising risk of spillover exposure. However, as Dutch is also spoken in this region, some risk of spillover cannot be fully excluded. Data collection Data will be collected through online surveys administered at two time points: baseline (T0; prior to campaign launch) and 2-year post-baseline (T1). The study uses two independent cross-sectional samples at T0 and T1 rather than repeated measurements in the same participants. Equivalent surveys will be administered in both the intervention and control regions to allow valid comparison across groups. The questionnaires will contain the same core content, with language and minor contextual adaptations where necessary. Measurements Primary outcome The primary outcome is pain-related knowledge, beliefs and attitudes about pain, which will be assessed using the Pain Concepts Questionnaire (PCQ) with the PCQ biopsychosocial–biomedical (BPS/BM) ratio score as the primary outcome. The PCQ consists of 23 items with responses scored on a 5-point Likert scale (1=strongly disagree to 5=strongly agree). It was developed as a literacy-adapted instrument to measure two different constructs: BM beliefs and BPS beliefs on pain, thereby providing a broad assessment of pain concepts. Subscale scores for the BM and BPS factors will be calculated as the mean of the items within each factor (range 1–5). A ratio score (BPS/BM) will be computed, with higher values reflecting a relatively higher biopsychosocial orientation to pain. The PCQ has been validated in English and was specifically developed with literacy adaptations to be appropriate for populations with low SES.25 A paper is currently in preparation on the Dutch and German validation of the PCQ. Secondary outcomes The self-reported items on healthcare utilisation and medication use were developed using a harmonised structure informed by validated international sources. The structure of the instrument follows the domains of the European Health Interview Survey, complemented by the Delphi-validated service categories.26 The recall period was standardised to 4 weeks, supported by evidence from the German "Studie zur Abbildung von Häufigkeiten von Reha-Inanspruchnahmen und –Bedarfen nach akutem Herzinfarkt" study, which also applies a 4-week utilisation timeframe. To ensure structural validity and applicability in the German context, the outpatient and emergency care categories were aligned with the German Health Update implementation of the European Health Interview Survey.27 Healthcare utilisation in the past 4 weeks will be assessed with self-reported items, including the type of healthcare provider visited, the frequency of visits, whether the care was received with or without hospital admission and whether the healthcare provider delivered care at home. For each service used, the number of contacts or days will be recorded and summarised descriptively, and, if applicable, converted into costs using standardised unit prices from national healthcare cost guidelines. Healthcare utilisation in the past 4 weeks will be assessed with self-reported items, including the type of healthcare provider visited, the frequency of visits, whether the care was received with or without hospital admission and whether the healthcare provider delivered care at home. For each service used, the number of contacts or days will be recorded and summarised descriptively, and, if applicable, converted into costs using standardised unit prices from national healthcare cost guidelines. Medication use will be assessed with self-reported items, including the drug name, dosage, form, frequency of intake and prescription status. To capture analgesic use, both prescription and over-the-counter medication will be recorded and summarised descriptively (see table 4). Medication use will be assessed with self-reported items, including the drug name, dosage, form, frequency of intake and prescription status. To capture analgesic use, both prescription and over-the-counter medication will be recorded and summarised descriptively (see table 4). Table 4Study measures and instrumentsMeasuresDescriptionMeasurement instrumentPrimary outcome:Pain-related knowledge, attitudes and beliefsPCQConstruct measured: Knowledge, beliefs and attitudes about pain (biomedical and biopsychosocial perspectives).Items: 23Response format: 5-point Likert scale (1=strongly disagree to 5=strongly agree)Scoring: Subscale scores for biomedical and biopsychosocial factors are calculated as the mean of items within each factor (range 1–5). A ratio score (BPS/BM) is computed, with higher values reflecting a stronger biopsychosocial orientation.Secondary outcomes:Healthcare utilisation in the past 4 weeksHarmonised healthcare utilisation instrumentConstruct measured: Use of healthcare services in the past 4 weeks due to pain (GP visits, specialist visits, hospital admissions, emergency care).Items: Multiple items covering type and frequency of healthcare contacts.Response format: Dichotomous (yes/no) with follow-up questions on frequency and duration (number of visits, days of admission).Scoring: Counts of contacts and days are reported per category.Medication use in the past 4 weeksHarmonised medication use instrumentConstruct measured: Analgesic use in the past 4 weeks, including prescription and over-the-counter medication.Items: Drug name, form, dosage, frequency of intake and prescription status.Response format: Open-ended entries and categorical options (yes/no, number of times per day).Scoring: Data reported descriptively (type, frequency, dosage).Sociodemographic variables:Age, gender, postal code, work status, work contact hours, monthly household income and size, education, ethnicity/cultural backgroundSelf-constructed items, based on RIVM guidelines and CBS classifications.Health variables:Mobility, self-care, activities of daily living, pain status and anxiety/depressionEQ-5D-5LConstruct measured: Health-related quality of life (mobility, self-care, usual activities, pain/discomfort, anxiety/depression).Items: 5Response format: 5-point Likert scale (1=no problems to 5=unable to/extreme problems).Scoring: Responses per dimension combined into a 5-digit health state profile (eg, 21 111=slight problems in mobility, no problems in other dimensions); converted to a utility index using national value sets (Germany, Netherlands, Belgium).Work-related variables:Weekly working hours, absenteeismiPCQConstruct measured: Weekly working hours and health-related absenteeism.Items: 2 (iPCQ items 2 and 4).Response format: Number of working hours per week; number of working days absent due to sickness in the past 4 weeks.Scoring: Descriptive analysis; higher scores indicate more working hours (item 2) or more absenteeism (item 4).BPS/BM, biopsychosocial–biomedical; CBS, Statistics Netherlands; EQ-5D-5L, EuroQol 5-Dimension 5-Level Questionnaire; GP, general practitioner; iPCQ, iMTA Productivity Cost Questionnaire; PCQ, Pain Concepts Questionnaire; RIVM, National Institute for Public Health and Environment. Study measures and instruments BPS/BM, biopsychosocial–biomedical; CBS, Statistics Netherlands; EQ-5D-5L, EuroQol 5-Dimension 5-Level Questionnaire; GP, general practitioner; iPCQ, iMTA Productivity Cost Questionnaire; PCQ, Pain Concepts Questionnaire; RIVM, National Institute for Public Health and Environment. Sociodemographic, health-related and work-related variables Sociodemographic variables: Sociodemographic information including age, gender, postal code, employment status, working hours, monthly household income and size, education and ethnic or cultural background will be measured using self-constructed and culturally adapted items based on established questionnaires and official classifications.28 Sociodemographic variables: Sociodemographic information including age, gender, postal code, employment status, working hours, monthly household income and size, education and ethnic or cultural background will be measured using self-constructed and culturally adapted items based on established questionnaires and official classifications.28 Health-related variables: Health-related variables, including health-related quality of life, will be collected using the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L) instrument of the EuroQol Group Association. This instrument covers five dimensions (mobility, self-care, activities of daily living, pain status and anxiety/depression), each rated on a 5-point scale ranging from no problems (coded as 1) to extreme problems (coded as 5). Established national value sets (weights) for Germany, the Netherlands and Belgium will be applied to the corresponding subsamples to calculate the Health Utility Index. Health-related variables: Health-related variables, including health-related quality of life, will be collected using the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L) instrument of the EuroQol Group Association. This instrument covers five dimensions (mobility, self-care, activities of daily living, pain status and anxiety/depression), each rated on a 5-point scale ranging from no problems (coded as 1) to extreme problems (coded as 5). Established national value sets (weights) for Germany, the Netherlands and Belgium will be applied to the corresponding subsamples to calculate the Health Utility Index. Work-related variables: Work-related variables, including weekly working hours and work absenteeism in the past 4 weeks, will be measured with two items from the iMTA Productivity Cost Questionnaire (iPCQ). Item 2 records the number of hours the participant works per week, and item 4 assesses the number of working days absent from paid work due to sickness in the past 4 weeks. Together, these items provide a measure of work status and health-related absenteeism. Work-related variables: Work-related variables, including weekly working hours and work absenteeism in the past 4 weeks, will be measured with two items from the iMTA Productivity Cost Questionnaire (iPCQ). Item 2 records the number of hours the participant works per week, and item 4 assesses the number of working days absent from paid work due to sickness in the past 4 weeks. Together, these items provide a measure of work status and health-related absenteeism. Process evaluation For the process evaluation, the following aspects will be assessed: fidelity, reach and dose. Fidelity, defined as the extent to which the intervention is delivered as intended,29 will be assessed by randomly reviewing 10% of all outputs (social media posts, radio/television spots, print materials) against a checklist covering key elements, namely: biopsychosocial perspective, B1 language level, consistency with core messages. For the HCP training, fidelity will be assessed using trainer checklists and session attendance records. Fidelity, defined as the extent to which the intervention is delivered as intended,29 will be assessed by randomly reviewing 10% of all outputs (social media posts, radio/television spots, print materials) against a checklist covering key elements, namely: biopsychosocial perspective, B1 language level, consistency with core messages. For the HCP training, fidelity will be assessed using trainer checklists and session attendance records. Reach, defined as the extent to which the target population is exposed to the intervention,29 will be assessed per platform, using analytics that estimate the number of users that were exposed at least once to the social media intervention. The theoretical target population is defined as 10% of the total EDR population. Reach will be described using platform analytics. Considering a chronic pain prevalence of approximately 20% in the region we expect a part of those reached to include individuals with chronic pain. However, a higher overall reach is anticipated, as multiple print and media sources will be used, for which the reach cannot be calculated. Reach, defined as the extent to which the target population is exposed to the intervention,29 will be assessed per platform, using analytics that estimate the number of users that were exposed at least once to the social media intervention. The theoretical target population is defined as 10% of the total EDR population. Reach will be described using platform analytics. Considering a chronic pain prevalence of approximately 20% in the region we expect a part of those reached to include individuals with chronic pain. However, a higher overall reach is anticipated, as multiple print and media sources will be used, for which the reach cannot be calculated. Dose, defined as the amount of intervention delivered and received,29 will be assessed using multiple indicators. Delivered dose will be assessed by recording the number of campaign outputs (eg, posts, newsletters, flyers). Received dose will be measured using the platform analytics, including impressions and click-through rates to the campaign website. It will also include the number of sessions delivered and attendance at HCP sessions. Dose, defined as the amount of intervention delivered and received,29 will be assessed using multiple indicators. Delivered dose will be assessed by recording the number of campaign outputs (eg, posts, newsletters, flyers). Received dose will be measured using the platform analytics, including impressions and click-through rates to the campaign website. It will also include the number of sessions delivered and attendance at HCP sessions. Potential confounders In this non-randomised study, six potential confounding variables will be included based on evidence from previous public health campaigns. Age and gender are known to influence pain prevalence and health-seeking behaviour.30 31 Postal code serves as a proxy for regional factors such as healthcare accessibility and environmental influences. Work status, income and education level reflect SES, which has been associated with both pain outcomes and health literacy.16 32 33 Because health literacy strongly shapes health-seeking behaviour, both constructs are relevant for understanding differences in prevention and care.10 11 Accordingly, prespecified potential confounders for the primary adjusted analysis are age, gender, education level, income, work status, and postal code or region-level indicators where appropriate. Sample size calculations The primary sample size calculation was conducted in PASS34 using the procedure ‘Tests for Two Groups of Pre-Post Scores’. This procedure tests the group-by-time interaction in a two-group pre–post design, corresponding to the planned difference-in-differences comparison of change in PCQ scores between the intervention and control regions. Because the study uses independent cross-sectional samples at baseline and follow-up rather than repeated measurements in the same participants, the pre–post correlation was set to 0. For the initial calculation, the Netherlands and Germany were combined as the intervention group and compared with Belgium as the control group. A two-sided α of 0.05, 80% power, an allocation ratio of 3:1 for intervention versus control participants, equal SD at baseline and follow-up, and a standardised difference in mean change of 0.18 SD were assumed. This last value was chosen as a conservative small effect, slightly below Cohen’s conventional benchmark of 0.20 SD for a small standardised mean difference, and in line with evidence that population-level mass-mediated health campaigns generally produce small but measurable effects.35 Under these assumptions, approximately 647 control participants and 1941 intervention participants were required per measurement wave, corresponding to approximately 2588 participants per wave. The final planned sample size was increased to 3200 participants per wave, comprising 1200 participants from the Netherlands, 1200 from Germany and 800 from Belgium. This enlarged sample allows detection of a smaller pooled intervention-versus-control difference in change of approximately 0.16 SD, improves precision for covariate-adjusted analyses, supports secondary country-specific comparisons, preserves robustness after incomplete responses or exclusions and supports representativeness across key demographic and socioeconomic strata. Secondary country-specific and subgroup analyses will be interpreted as exploratory. Two additional sensitivity calculations were conducted. First, using the planned pooled allocation of 2400 intervention participants and 800 control participants per wave, the study was estimated to have 80% power to detect a standardised difference in mean change of approximately 0.16 SD. Second, for country-specific secondary comparisons, using approximately 1200 participants from one intervention country and 800 control participants per wave, the study was estimated to have 80% power to detect a standardised difference in mean change of approximately 0.18 SD. Statistical analysis The primary analysis will evaluate whether the change in pain-related knowledge, attitudes and beliefs from baseline to follow-up differs between the intervention regions and the control region. The primary analysis population will include all survey participants from the relevant study regions who provide valid data on the primary PCQ outcome at the corresponding measurement wave. Participants will be analysed according to the region from which they were sampled. The primary outcome will be the PCQ BPS/BM ratio score, measured at baseline and 2-year follow-up. Because the study uses independent cross-sectional samples at baseline and follow-up, the analysis will be conducted at participant level using linear regression models rather than repeated-measures models. A linear mixed model with country specified as a random effect was not considered appropriate, because the intervention is implemented at country or regional level and only three country-level units are included. With so few higher-level units, a random-effect variance for country cannot be estimated reliably; therefore, country or study region will be included as a fixed effect. The primary model will be an adjusted linear regression model including fixed effects for time, study group and the interaction between time and study group. Time will be coded as baseline versus follow-up. For the primary comparison, the Netherlands and Germany will be combined as the intervention group and compared with Belgium as the control group. The Netherlands and Germany are combined because both regions are exposed to the same campaign and jointly represent the intervention condition. Country-specific analyses for the Netherlands and Germany will be conducted as secondary analyses to explore potential heterogeneity between intervention regions. The time×group interaction term will estimate the difference in mean change in PCQ score between the intervention and control groups, corresponding to the primary difference-in-differences estimand. Secondary analyses will examine the Netherlands and Germany separately by including country as a three-level fixed effect, with Belgium as the reference category. In this model, the country-specific time×country interaction terms will estimate the difference in change over time for the Netherlands versus Belgium and Germany versus Belgium, respectively. These country-specific analyses will be interpreted as secondary. Secondary outcomes, including healthcare utilisation, medication use, health-related quality of life and work absenteeism, will be analysed descriptively and, where appropriate, using regression models suitable for the distribution of the outcome. Continuous outcomes will be analysed using linear regression models, binary outcomes using logistic regression models and count outcomes using Poisson or negative binomial regression models, depending on the distribution and evidence of overdispersion. Sensitivity analyses will include an unadjusted difference-in-differences model and, if applicable, analyses using multiple imputation for missing covariates. No interim analyses of effectiveness are planned. Missing data will be summarised for all study variables, including the primary outcome, covariates and secondary outcomes. The primary analysis will include participants with observed PCQ outcome data and available data on the covariates included in the adjusted model. If covariate missingness is substantial and the missing-at-random assumption is considered plausible based on observed participant characteristics, multiple imputation will be used as a sensitivity analysis. Complete-case and imputed analyses will be compared with assess robustness. Missing outcome data will not be imputed in the primary analysis. Exploratory equity-specific analyses will be conducted to examine whether the association between campaign implementation and change in PCQ scores differs across key sociodemographic groups. These analyses will be performed by adding interaction terms to the primary model, for example time×group×education, time×group×gender, time×group×income or time×group×occupational status. Where sample size permits, selected intersectional subgroup analyses combining two sociodemographic indicators may be explored. These analyses will be considered exploratory and hypothesis-generating, because the study is not primarily powered for subgroup effects. Given the quasi-experimental design, intervention allocation at regional level and the inclusion of one control region, findings will be interpreted as associations between campaign implementation and changes in outcomes rather than as definitive causal effects. All analyses will be conducted using IBM SPSS Statistics, V.28,36 or equivalent statistical software. Economic evaluation A cost–benefit analysis will be conducted to estimate the monetary differences in healthcare utilisation, pain-medication use and productivity losses between the intervention countries and the control region. Pain-medication use will be valued using standardised unit costs and, if applicable, classified using Anatomical Therapeutic Chemical codes to ensure comparability across drug types. Productivity-related indicators include paid weekly working hours and sickness-related absenteeism. All measures are self-reported and refer to the previous 4 weeks. Economic outcomes will be analysed using the same before–after control framework specified in the main analysis plan, with the Netherlands and Germany considered as the intervention regions and Belgium as the control region. Country-specific analyses may be performed as secondary analyses. A Social Return on Investment (SROI) analysis will be conducted to capture the broader societal value associated with the campaign, including changes in pain-related knowledge, attitudes and beliefs, healthcare utilisation, medication use and work-related outcomes beyond direct monetary savings. Relevant outcomes for the SROI analysis include changes in pain beliefs, shifts in healthcare-seeking behaviour and changes in healthcare utilisation patterns. This analysis will use pre–post comparisons between the intervention countries and Belgium as the control region, with adjustments to account for effects that would have occurred without the campaign. Monetisation will rely on national unit costs or published literature for impacts on healthcare utilisation as well as productivity, while outcomes without suitable monetary proxies will be reported descriptively. The SROI analysis intends to estimate the societal value associated per euro invested in the campaign. Study registration For transparency, the approved protocol has been made publicly available on the Open Science Framework (OSF; https://osf.io/vpzmn; archived on 28 April 2026). The OSF record is an archive and does not constitute formal study registration. Patient and public involvement Members of the public and relevant target groups were involved in the early development phase of this study. Their views informed the identification of relevant subgroups, as well as the development and review of the campaign content. Input was obtained through interviews and co-creation activities with members of the public, representatives of intended target groups and representatives from the collaborative partnership of pain patient organisations ‘Pijnpatienten naar een stem’, to explore their experiences, views and preferences regarding a public health campaign on chronic pain. Their input informed the identification of relevant subgroups and contributed to the development and review of the campaign content. Based on this input, the wording, framing, comprehensibility and format of the campaign materials were further developed and refined, and appropriate dissemination channels were identified. This input also informed the design of the present study by helping to ensure that the campaign materials and procedures were relevant, understandable and appropriate for the target population. Members of the public were not involved in participant recruitment or the direct conduct of the survey procedures. However, their input was used to improve the relevance, comprehensibility and accessibility of the campaign materials and study procedures. As participation in this study is limited to exposure to campaign materials and completion of questionnaires, the burden of participation was expected to be low. Study findings will be disseminated through peer-reviewed publications and conference presentations. Where appropriate, relevant findings and campaign outputs will also be shared with public and regional stakeholder groups in accessible formats. Ethics and dissemination Research ethics approval This study protocol was reviewed by the Medical Ethics Review Board of the University Medical Center Groningen (METc UMCG) and the University of Oldenburg. The study was considered not subject to the Medical Research Involving Human Subjects Act (Dutch: Wet medisch-wetenschappelijk onderzoek met mensen (WMO); non-WMO declaration, reference number M24.345555, issued on 31 December 2024) and was approved by the University of Oldenburg Ethics Committee (reference number 2025–056, issued on 7 March 2025), respectively. Protocol amendments Important protocol modifications (eg, changes in eligibility criteria, outcomes or analyses) will be submitted to the ethics committee for approval prior to implementation. Relevant parties, including collaborators and participating institutions, will be informed of the amendments. Participant consent Informed consent was obtained electronically by the research agency at the time of participants’ registration with the research panel, as described in the Methods section. Confidentiality All data will be anonymised during data collection and accessible only by the principal investigator and authorised study delegates. Access will be granted only after authorisation by the principal investigator. All source data, digital files and study documentation will be retained for 15 years in accordance with UMCG policy. Data management procedures comply with the General Data Protection Regulation and institutional data protection policies. Ancillary and post-trial care This study does not involve clinical interventions, and no harms related to participation are anticipated. Therefore, no ancillary or post-trial care is applicable. Dissemination policy The results of this study, whether positive or negative, will be published in a peer-reviewed journal. Abstracts will also be submitted to relevant national and international conferences. Footnotes Funding: This study is part of the Pain in the Ems Dollart region project which is financially supported by the Interreg VI programme Deutschland-Nederland under grant/award number 31107. Interreg as the trial sponsor, provided financial support only and had no role in the design, conduct, analysis, interpretation or reporting of the study, nor any authority over these activities. Prepublication history for this paper is available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2026-117258). Data availability free text: Not applicable. This is a study protocol and no datasets were generated or analysed for this manuscript. Patient consent for publication: Not applicable. Provenance and peer review: Not commissioned; externally peer reviewed. Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details. References